• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Utility before business.

作者信息

Teutsch Steven M, Fielding Jonathan E, Khoury Muin J, Evans James P

机构信息

Department of Public Health, Los Angeles County, Los Angeles, California, USA.

1] Department of Public Health, Los Angeles County, Los Angeles, California, USA [2] Fielding School of Public Health, University of California, Los Angeles, California, USA [3] Schools of Medicine, University of California, Los Angeles, California, USA.

出版信息

Genet Med. 2014 Dec;16(12):869-70. doi: 10.1038/gim.2014.71. Epub 2014 Jul 10.

DOI:10.1038/gim.2014.71
PMID:25010054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4690454/
Abstract
摘要

相似文献

1
Utility before business.公益先行，商业为后。
Genet Med. 2014 Dec;16(12):869-70. doi: 10.1038/gim.2014.71. Epub 2014 Jul 10.
2
Addressing health disparities in cancer with genomics.利用基因组学解决癌症中的健康差异问题。
Nat Rev Genet. 2021 Oct;22(10):621-622. doi: 10.1038/s41576-021-00390-4.
3
Valuable Genomes: Taxonomy and Archetypes of Business Models in Direct-to-Consumer Genetic Testing.有价值的基因组：直接面向消费者的基因检测中商业模式的分类与原型
J Med Internet Res. 2020 Jan 21;22(1):e14890. doi: 10.2196/14890.
4
The business of genomic testing: a survey of early adopters.基因检测业务：早期采用者调查
Genet Med. 2014 Dec;16(12):954-61. doi: 10.1038/gim.2014.60. Epub 2014 Jul 10.
5
The evolving clinical testing landscape of genomic aberrations in solid tumors and hematological malignancies - Insights from evidence-based reviews for B-ALL and breast, brain, and renal cell neoplasia.实体瘤和血液系统恶性肿瘤中基因组畸变的临床检测格局演变——基于循证综述对B细胞急性淋巴细胞白血病及乳腺、脑和肾细胞瘤的见解
Cancer Genet. 2020 Jun;244:60-61. doi: 10.1016/j.cancergen.2020.04.001. Epub 2020 Apr 28.
6
Genetic Testing: How Genetics and Genomics Can Affect Healthcare Disparities
.基因检测：遗传学和基因组学如何影响医疗保健差异
Clin J Oncol Nurs. 2018 Feb 1;22(1):116-118. doi: 10.1188/18.CJON.116-118.
7
The evidence for expanded genetic testing for pediatric patients with cancer.对患有癌症的儿科患者进行扩大基因检测的证据。
Future Oncol. 2018 Feb;14(3):187-190. doi: 10.2217/fon-2017-0467. Epub 2018 Jan 12.
8
The Next Generation of Molecular Pathology is Here: Validation of Next-Generation Sequencing Technology for Clinical Molecular Testing Across Multiple Different Disciplines.新一代分子病理学已至：跨多个不同学科的临床分子检测中下一代测序技术的验证。
Arch Pathol Lab Med. 2017 Jun;141(6):749-750. doi: 10.5858/arpa.2017-0042-ED.
9
"Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.“体细胞”肿瘤基因组分析及潜在的种系影响：癌症患儿的伦理考量
J Law Med Ethics. 2020 Dec;48(4):778-783. doi: 10.1177/1073110520979389.
10
Genomic testing: a struggle for oncologists.基因组检测：肿瘤学家面临的一项难题。
J Natl Cancer Inst. 2014 Jun 6;106(6):dju172. doi: 10.1093/jnci/dju172. Print 2014 Jun.

引用本文的文献

1
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.风险调整后的癌症筛查与预防（RiskAP）：通过基于风险因素的学习型筛查补充早期疾病检测筛查
Breast Care (Basel). 2022 Apr;17(2):208-223. doi: 10.1159/000517182. Epub 2021 Aug 12.

本文引用的文献

1
The business of genomic testing: a survey of early adopters.基因检测业务：早期采用者调查
Genet Med. 2014 Dec;16(12):954-61. doi: 10.1038/gim.2014.60. Epub 2014 Jul 10.
2
Clinical application of whole-genome sequencing: proceed with care.全基因组测序的临床应用：谨慎推进。
JAMA. 2014 Mar 12;311(10):1017-9. doi: 10.1001/jama.2014.1718.
3
Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.按证据水平优先考虑基因组应用的行动：一种 horizon-scanning 方法。
Clin Pharmacol Ther. 2014 Apr;95(4):394-402. doi: 10.1038/clpt.2013.226. Epub 2014 Feb 19.
4
Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.个性化医疗中基因检测的经济分析：临床效用优先，然后是成本效用。
Genet Med. 2014 Mar;16(3):225-7. doi: 10.1038/gim.2013.158. Epub 2013 Oct 10.
5
Special report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders.特别报告：外显子组测序用于疑似遗传性疾病患者的临床诊断
Technol Eval Cent Assess Program Exec Summ. 2013 Aug;28(3):1-4.
6
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
7
The arrival of genomic medicine to the clinic is only the beginning of the journey.基因组医学进入临床领域仅仅是这一旅程的开端。
Genet Med. 2013 Apr;15(4):268-9. doi: 10.1038/gim.2012.133. Epub 2013 Jan 10.
8
A health dividend for America: the opportunity cost of excess medical expenditures.美国的健康红利：过度医疗支出的机会成本。
Am J Prev Med. 2012 Dec;43(6):650-4. doi: 10.1016/j.amepre.2012.08.013.
9
Outcomes of interest in evidence-based evaluations of genetic tests.基于证据的基因检测评估中的研究结果。
Genet Med. 2010 Apr;12(4):228-35. doi: 10.1097/GIM.0b013e3181cdde04.